Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ragosch

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Enzyme & Protein|January 1, 1993
11-beta-Hydroxysteroid dehydrogenase of rat lung: enzyme kinetic, oxidase-reductase ratio, electrolyte and trace element dependenceS Hundertmark, V Ragosch, B Schein, et al.
Journal of Perinatal Medicine|January 1, 1996
Indication and results of insulin therapy for gestational diabetes mellitusH Hopp, W Vollert, V Ragosch, et al.
European Journal of Medical Research|August 3, 2025
Expression of the novel serum biomarker of testicular germ cell tumours miR-371a-3p in serum of pregnant women: a case-control studyK P Dieckmann, M Hubert, V Ragosch, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 12, 2004
Impairment of the antiproliferative effect of glucocorticosteroids by 11beta-hydroxysteroid dehydrogenase type 2 overexpression in MCF-7 breast-cancer cellsC Lipka, J Mankertz, M Fromm, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 11, 2001
Ontogeny of 11beta-hydroxysteroid dehydrogenase: activity in the placenta, kidney, colon of fetal rats and rabbitsS Hundertmark, H Bühler, M Fromm, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 20, 2002
11beta-hydroxysteroid dehydrogenase type 1: a new regulator of fetal lung maturationS Hundertmark, A Dill, H Bühler, et al.
Breast (Edinburgh, Scotland)|August 25, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trialJ Huober, P A Fasching, M Barsoum, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Enzyme & Protein|January 1, 1993
11-beta-Hydroxysteroid dehydrogenase of rat lung: enzyme kinetic, oxidase-reductase ratio, electrolyte and trace element dependenceS Hundertmark, V Ragosch, B Schein, et al.
Journal of Perinatal Medicine|January 1, 1996
Indication and results of insulin therapy for gestational diabetes mellitusH Hopp, W Vollert, V Ragosch, et al.
European Journal of Medical Research|August 3, 2025
Expression of the novel serum biomarker of testicular germ cell tumours miR-371a-3p in serum of pregnant women: a case-control studyK P Dieckmann, M Hubert, V Ragosch, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 12, 2004
Impairment of the antiproliferative effect of glucocorticosteroids by 11beta-hydroxysteroid dehydrogenase type 2 overexpression in MCF-7 breast-cancer cellsC Lipka, J Mankertz, M Fromm, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 11, 2001
Ontogeny of 11beta-hydroxysteroid dehydrogenase: activity in the placenta, kidney, colon of fetal rats and rabbitsS Hundertmark, H Bühler, M Fromm, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 20, 2002
11beta-hydroxysteroid dehydrogenase type 1: a new regulator of fetal lung maturationS Hundertmark, A Dill, H Bühler, et al.
Breast (Edinburgh, Scotland)|August 25, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trialJ Huober, P A Fasching, M Barsoum, et al.
Pageof 3